A new study of non-diabetic women with ovarian cancer reveals a potential correlation and area for further study regarding the expression of the GLUT1 glucose transporter receptor at the cancer tissue level. GLUT1 is a receptor protein involved in the absorption of glucose, or sugar, in the bloodstream and across membranes in the body.
An experimental treatment in mice allows the reprogramming of blood cells in order to promote the healing process of cutaneous wounds. This novel approach published recently in Journal of Investigative Dermatology could prove to be beneficial in healing challenging wounds in diabetics and major-burn victims.
Scientists at the University of Texas at Dallas have found that a protein responsible for transporting glucose — a kind of sugar — into cells is present in significantly higher levels in lung squamous cell carcinoma than in lung adenocarcinoma.
• Patients who received kidney transplants from donors with diabetes had better survival compared with those who remained on the waitlist. • Patients at high risk of dying while on the waitlist and those at centers with long wait times may benefit the most from transplantation with kidneys from diabetic donors.
New Michigan State University research is the first to help a professional race car driver with diabetes improve his performance during competition, helping him capture two top-5 finishes at the Indianapolis 500.
Dr. Ming-Hui Zou, director of the Center for Molecular & Translational Medicine and a Georgia Research Alliance Eminent Scholar in Molecular Medicine, has renewed a four-year, $2.3 million federal grant to study the role of an enzyme in causing diabetic vascular diseases and the molecular mechanism that leads to these diseases.
Researchers at the University of Michigan, Stanford University and biotech company ConfometRx have captured the first cryo-electron microscopy snapshots of a key cellular receptor in action.
The Endocrine Society warned that the President’s proposal to slash $7.16 billion, or more than a fifth, of the National Institutes of Health’s (NIH’s) budget, and $1.2 billion from the Centers for Disease Control and Prevention (CDC) would hinder progress toward needed medical treatments and advances in public health and disease prevention.
Bronx residents impacted by diabetes, led by Health People, will protest the city's complete failure to implement effective diabetes prevention at Mayor de Blasio's Bronx visit at 9am at the Bronx County Courthouse at 161 Street and Grand Concourse.
Research led by the University of Adelaide is paving the way for safer and more effective drugs to treat type 2 diabetes, reducing side effects and the need for insulin injections.
Hundreds of thousands of children with chronic illnesses who used to die are now surviving their disease and treatment—which is amazing. But their brains are being damaged in the process of keeping them alive. This first ever research quantifies the IQ impact of six main illnesses and looks and the common threads that connect them. It also takes next steps on how psychologists can team up with surgeons/oncologists, etc. to help treat kids and their parents, so they can thrive in school and life.
Metformin, the most widely used drug to treat type 2 diabetes, could potentially be used to treat symptoms of Fragile X syndrome, an inherited form of intellectual disability and a cause of some forms of autism.
Beth Israel Deaconess Medical Center’s (BIDMC) Barbara B. Kahn, MD, an international leader in the field of diabetes, endocrinology and metabolism, has been elected to the prestigious National Academy of Sciences (NAS).
UT Southwestern research investigating the blood glucose-regulatory actions of the hormone ghrelin may have implications for development of new treatments for diabetes.
"Unprevented Diabetes Means Unnecessary Alzheimer's", a report by Health People: Community Preventive Health Institute projects that without prevention for New York City's estimated 1.3 million pre-diabetics and for New York State's 5.4 million pre-diabetics, city diabetes cases will rise by 325,000 cases in five years and overall state diabetes cases by 1.35 million cases; based on reach research, these new cohort of diabetics are at a 40% increased risk for developing Alzheimer's over time.
Researchers have developed a new technique that uses modified insulin and red blood cells to create a glucose-responsive “smart” insulin delivery system. In an animal model study, the new technique effectively reduced blood sugar levels for 48 hours in a strain of mice that had Type 1 diabetes.
With diabetes raising the risk for Alzheimer’s Disease by 40%, New Yorkers are facing an escalating Alzheimer's epidemic fueled by failures of New York City and State to undertake effective diabetes prevention.
Researchers have identified a gene that plays a key role in the formation of neural tube defects, a problem commonly found in infants of pregnant women with diabetes. This is the first time the gene has been shown to play this role; it opens up a new way to understand these defects, and may one day lead to new treatments that could prevent the problem or decrease its incidence.
Researchers investigating a form of adult-onset diabetes that shares features with the two better-known types of diabetes have discovered genetic influences that may offer clues to more accurate diagnosis and treatment. The study team found that latent autoimmune diabetes in adults (LADA) is genetically closer to type 1 diabetes than to type 2 diabetes.
It's obvious that the taste buds on the tongue can detect sugar. And after a meal, beta cells in the pancreas sense rising blood glucose and release the hormone insulin—which helps the sugar enter cells, where it can be used by the body for energy.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right